Editorial Article
The Same Toxin Is Legal at 300 Parts Per Billion for a Beef Cow and 20 for a Dairy Cow, and That One Fact Explains a USD 3.3 Billion Market
Two rows from the same table, in the same document, published by the same regulator. Corn and peanut products intended for finishing beef cattle: aflatoxin permitted to 300 parts per billion. Corn and peanut products intended for dairy animals, or for species and uses not otherwise specified: 20 parts per billion.
Nothing about the molecule changes between those rows. Same toxin, same commodity, same country, same inspector. What changes is the animal, and specifically what happens downstream of the animal. The limit is not a property of the chemistry. It is a property of the physiology, and of the human food chain that sits behind it.
That one design choice — to set the limit by species rather than by toxin or by commodity — is the most consequential fact in a market that Pheonix Research sizes at USD 3.28 billion in 2025 across mycotoxin testing and feed mycotoxin binders, reaching USD 5.80 billion by 2033. It is why the demand is durable, why it cannot be engineered away, and why a bad harvest does not simply reduce the market but reorganises it.
The rows, and the reason for them
The US Food and Drug Administration’s Compliance Policy Guide Sec. 683.100 sets action levels for aflatoxins in animal food, and it reads as a ladder. The most tolerant rung is finishing beef cattle, at 300 ppb, and cottonseed meal at the same level regardless of which species it is fed to. Then 200 ppb for finishing swine over 100 pounds. Then 100 ppb for breeding beef cattle, breeding swine and mature poultry. Then 20 ppb for immature animals, and 20 ppb for dairy animals and any use not specified.
| Intended use | Aflatoxin action level |
|---|---|
| Corn and peanut products, finishing (feedlot) beef cattle | 300 ppb |
| Cottonseed meal, beef cattle, swine or poultry | 300 ppb |
| Corn and peanut products, finishing swine of 100 lb or more | 200 ppb |
| Corn and peanut products, breeding beef cattle, breeding swine, mature poultry | 100 ppb |
| Corn, peanut products and other feeds, immature animals | 20 ppb |
| Dairy animals, species or uses not specified, or use not known | 20 ppb |
| Milk — aflatoxin M1 | 0.5 ppb |
The internal logic is visible once you look at the two 20 ppb rows together with the last one. A dairy cow converts aflatoxin B1 into aflatoxin M1, which is excreted in milk, and milk is consumed by infants in large quantity relative to body weight. So the tolerance at the cow has to be tight enough that the metabolite stays below 0.5 ppb in the product. The 20 ppb figure is not a judgement about how much aflatoxin a cow can tolerate. It is a judgement about how much a human infant can tolerate, expressed one step back up the chain.
Swine breeding stock and mature poultry sit at 100 ppb because breeding performance is the sensitive endpoint. Finishing swine at 200 ppb because the animal is close to slaughter and the exposure window is short. Finishing beef cattle at 300 ppb because the rumen is comparatively tolerant and the animal is measured in months, not years. Every rung is a different physiological argument. None of them is a different chemical fact.
What follows for the buyer
Three consequences follow, and they are commercial before they are scientific.
Testing frequency is set by destination, not by contamination risk. A single lot of corn may go to a dairy customer and to a feedlot. If it does, it needs two results against two specifications, because a lot that complies at 200 ppb does not comply at 20. A trader who routes one silo to three customers is running three compliance arguments on one physical asset — and the analytical work is a function of the routing table, not of how contaminated the grain is. This is the mechanism behind the volume line in this market: tests rise 6.43 per cent a year to 158.0 million by 2033, while the realised price of a test rises 0.54 per cent a year, because the number of tests is driven by the number of decisions rather than by the number of tonnes.
The binder decision is set by the same species logic. A dairy ration at 20 ppb has almost no headroom, which is why dairy and breeding customers dose prophylactically — not because they have evidence of a problem in this particular batch, but because the cost of discovering one after the milk has been collected is not survivable. That is insurance, bought by species, and it is why the binder tonnage in this market grows at 5.01 per cent a year while the price of a tonne rises 2.54 per cent a year. The volume is a compliance decision. The price is a claim about risk.
A lot that fails a food limit does not disappear. It becomes feed. This is the third consequence, and it is where the testing market and the binder market join. Food limits are tighter than feed limits, so the routing logic of a bad harvest is a cascade: grain that cannot be sold as food is declassified to feed, where a looser limit applies, and where a binder makes the difference between a usable ration and a rejected one. Every declassification event creates binder demand, and every tightening of a feed limit raises the dose required to clear it.
COCERAL, presenting its mycotoxin management report to an EFSA standing group in June 2025, described exactly that pressure. Its members expect aflatoxins and ochratoxins in corn, deoxynivalenol and the T-2 and HT-2 toxins in all cereals, and zearalenone and Alternaria toxins in oilseeds to become more prevalent over the next decade. Its stated future constraint is that a growing share of grain fit for human consumption will have to be declassified to feed as food limits are missed — and that in the worst case some corn will not meet the limits set for feed material either.
That is the mechanism that makes the two halves of this market sequential rather than parallel. The test is the gate: it decides whether a lot may be sold as food, must be downgraded, or must be rejected. The binder is the toll: it is what makes the downgraded lot usable. This is why the argument that the two markets should be treated separately, and the fact that their most sophisticated owner has just decided to sell them separately, are worth watching against each other.
The same argument runs in Europe, in a different instrument
The European Union does not use an action-level guide. It uses maximum levels set in Commission Regulation (EU) 2023/915, which consolidated the previous contaminants framework and has been amended repeatedly since April 2023 — eleven times in under three years at the last count taken for this analysis, most recently by (EU) 2026/1825 of 29 July 2026. Roughly one amendment every three to four months.
Three to four months is faster than the revalidation cycle of an accredited laboratory method. The commercial effect of that timing is not obvious until you follow it through. Revalidating a single-analyte method is a fixed cost per method, per site. Revalidating one multi-analyte method that returns twenty toxins in a single injection spreads that fixed cost across twenty results. Regulatory churn therefore pushes laboratories toward the technology with the lowest price per analyte — which is one of the reasons the realised value of a test in this market stays so flat while the volume grows. The regulation that creates the demand also accelerates the commoditisation of the supply.
| Instrument | What it governs | Effect on this market |
|---|---|---|
| FDA Compliance Policy Guide Sec. 683.100 | Aflatoxin action levels in animal food, set by species and use | Creates destination-specific testing; drives prophylactic dosing in dairy and breeding |
| Commission Regulation (EU) 2023/915 | Maximum levels for contaminants in food, amended frequently | Method revalidation every cycle; pushes labs to multi-analyte methods |
| Codex Alimentarius CXS 193-1995 | International maximum levels; reference in trade disputes | Sets the practical level where exporter and importer limits disagree |
| Regulation (EC) No 1831/2003 | Authorisation of feed additives, including mycotoxin binders | Establishes safety; does not certify efficacy, which is why binder price holds |
The fourth row is the one that decides the money. Under that regulation a binder is authorised as a technological additive, and authorisation requires a safety assessment and an efficacy assessment. When EFSA’s FEEDAP panel assessed a bentonite-and-sepolite preparation for all animal species in 2013, it found the product safe up to 20,000 mg/kg of complete feed and concluded that there was insufficient evidence to conclude on its efficacy, on the basis of a single in vivo study in chickens. Safety established. Efficacy not.
That is why the two halves of this market diverge in price. A test is anchored to a published reference method, so the reagent is comparable and the price converges to USD 14.79 a test. A binder is anchored to nothing comparable, so it is sold on formulation, on trial data and on advice — and the price rises to USD 7,104 a tonne. The regulatory framework that governs the limits is the same framework, in a sense, that governs the products: one half of it is precise and the other is permissive, and the market has priced that difference correctly.
The climate does not change the argument, it repeats it
The European Environment Agency’s assessment of mycotoxin exposure in a changing European climate, published in March 2025, found that Europe has been warming at twice the global average — the fastest-warming continent — and modelled aflatoxin contamination in maize under warming scenarios. Under +2°C, contamination rises particularly in Spain, Italy and the Balkans. Under +5°C, southern risk may fall as extreme heat suppresses fungal growth, while the risk band widens into northern Europe.
The agency’s framing is the one worth carrying: the highest risk of climate-driven mycotoxin contamination sits in developed countries with moderate climates. Those are the markets where testing infrastructure and binder use are already mature, and where every additional positive result is a purchase order for both.
None of that changes the species logic. A warmer Europe does not adjust the dairy limit; it puts more lots into the band where the dairy limit bites. The limit stays where it is, the routing decision becomes more frequent, and the market grows because the number of decisions grows.
Why this cannot be engineered away
The instinctive response to a compliance problem is to assume technology will dissolve it. In this market that instinct is wrong in a specific and useful way. Analytical capability has already outrun the problem it was bought to solve: tandem mass spectrometry reaches sub-parts-per-billion detection routinely, against limits measured in tens or hundreds of parts per billion. Better instruments cannot help, because the constraint is no longer detection.
The constraint is sampling — whether the increment that reached the laboratory represents the lot — and interpretation, which is whether a result near a limit means anything at all. And the deeper constraint is the one this article opened with: the limit is a property of the species, not of the toxin, and no advance in chemistry can collapse a fifteen-fold spread that exists because a dairy cow excretes what it eats into milk.
That is the structural reason this market is worth more in 2033 than in 2025. Not because the grain is getting worse, though in some regions it may be. Because the number of occasions on which a lot has to be proven against a species-specific limit keeps rising, and each of those occasions requires a result, and a meaningful share of them requires a binder.
Action levels cited are from the US FDA’s Compliance Policy Guide Sec. 683.100, Action Levels for Aflatoxins in Animal Food, read with the agency’s guidance on action levels for poisonous or deleterious substances in human food and animal feed. Market figures are drawn from Global Mycotoxin Testing & Feed Binder Market Report, Size, Share and Forecast 2026–2033, and the two companion reports in the same segment, Global Food Safety Testing and Global Food Allergen Testing & Control. Grain-side context sits in Global Corn (Maize) Seed. The European amendment count is carried from the preceding report in this cluster rather than re-derived.
Frequently Asked Questions
Why is aflatoxin permitted at 300 ppb for beef cattle but only 20 ppb for dairy cows?
Because the limit is set by what happens to the animal's product, not by how much the animal can tolerate. A dairy cow converts aflatoxin B1 into aflatoxin M1, which is excreted in milk, and milk is consumed by infants in large quantity relative to body weight. The 20 ppb feed level exists to keep the metabolite below the 0.5 ppb action level for M1 in milk. The 300 ppb level for finishing beef cattle reflects a more tolerant rumen and a short exposure window before slaughter.
Why does testing volume grow faster than the tonnage being tested?
Testing frequency is set by destination rather than by contamination risk. A single lot of corn routed to a dairy customer and a feedlot needs two results against two specifications, because a lot that complies at 200 ppb does not comply at 20. A trader routing one silo to three customers is running three compliance arguments on one physical asset, so the analytical work scales with the number of routing decisions rather than with the tonnage.
What happens to grain that fails a food safety limit?
Food limits are tighter than feed limits, so a bad harvest does not destroy grain — it re-routes it. Grain that cannot be sold as food is declassified to feed, where a looser limit applies and a mycotoxin binder makes the difference between a usable ration and a rejected one. COCERAL told an EFSA standing group in June 2025 that a growing share of food-grade grain will be downgraded to feed as food limits are missed, and that in the worst case some corn will not meet the feed limits either.
How are mycotoxin binders regulated, as opposed to mycotoxin tests?
It falls under Regulation (EC) No 1831/2003, which requires both a safety and an efficacy assessment. When EFSA's FEEDAP panel assessed a bentonite-and-sepolite preparation in 2013 it found it safe up to 20,000 mg/kg of complete feed but concluded there was insufficient evidence to conclude on efficacy. So the framework establishes that a binder is safe, not that it works — and that absence of a certified measure of effect is what allows binder prices to rise 2.54 per cent a year while test prices rise 0.54 per cent.
